Numinus Wellness (TSE:NUMI) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Numinus Wellness Inc. reported a slight decline in revenue and gross profit in Q3 of Fiscal 2024, alongside a modest cash position and an increased number of client appointments in the U.S. They have transitioned out of Canadian clinical operations to focus on U.S. clinics and late-stage drug trials. Additionally, Numinus is planning to acquire MedBright AI Investments Inc., extending its reach in mental health care through a stock-based transaction.
For further insights into TSE:NUMI stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money